Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Crossref

1. Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’

- Seyed M. Alavian

- Heidar Sharafi

2. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting

- Heidar Sharafi

- Hossein Poustchi

- Fatemeh Azimian

- Babak Tamadoni

- Rashid Ramezani

- Mohamad Mehdi Gouya

- Mahdi Sheikh

- Farnaz Hashemi

- Mehrzad Tashakorian

- Ramin Alasvand

- Seyed Moayed Alavian

- Shahin Merat

3. Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

- Heidar Sharafi

- Bita Behnava

- Alireza Azizi-saraji

- Ali Namvar

- Ali Anvar

- Shima Salimi

- Seyed Moayed Alavian

4. Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis

- Hugo Perazzo

- Rodolfo Castro

- Paula M Luz

- Mariana Banholi

- Rafaela V Goldenzon

- Sandra W Cardoso

- Beatriz Grinsztejn

- Valdilea G Veloso

5. Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study

- Mohammad Tasavon Gholamhoseini

- Heidar Sharafi

- Helena HL Borba

- Seyed Moayed Alavian

- Asma Sabermahani

- Behzad Hajarizadeh

6. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

- Heidar Sharafi

- Seyed Moayed Alavian

7. Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review

- Saman Mohazzab-Torabi

- Fardin Dolatimehr

- Heidar Sharafi

- Mahdi Safi-Abadi

- Mohammad Saeid Rezaee-Zavareh

- Ehsan Bayatpour

- Hamidreza Karimi-Sari

- Seyed Moayed Alavian

8. Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank

- Heidar Sharafi

- Saeideh Maleki

- Seyed Moayed Alavian

9. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank

- Heidar Sharafi

- Saman Ghalamkari

- Alireza Hassanshahi

- Seyed Moayed Alavian

10. Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

- Hossein Ghaderi-Zefrehi

- Heidar Sharafi

- Farzin Sadeghi

- Mohammad Gholami-Fesharaki

- Alireza Farasat

- Fatemeh Jahanpeyma

- Seyed Moayed Alavian

11. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country

- Marcarious M. Tantuoyir

- Muhammed Camara

- Marjan Sohrabi

- SeyedAhmad SeyedAlinaghi

- Zahra Ahmadinejad

12. Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017

- Seyed Moayed Alavian

- Heidar Sharafi